These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32979397)

  • 1. Endocannabinoid metabolism and transport as targets to regulate intraocular pressure.
    Miller S; Daily L; Dharla V; Gertsch J; Malamas MS; Ojima I; Kaczocha M; Ogasawara D; Straiker A
    Exp Eye Res; 2020 Dec; 201():108266. PubMed ID: 32979397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model.
    Miller S; Leishman E; Hu SS; Elghouche A; Daily L; Murataeva N; Bradshaw H; Straiker A
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3287-96. PubMed ID: 27333182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain.
    Leishman E; Cornett B; Spork K; Straiker A; Mackie K; Bradshaw HB
    Pharmacol Res; 2016 Aug; 110():159-172. PubMed ID: 27109320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure.
    Miller S; Leishman E; Oehler O; Daily L; Murataeva N; Wager-Miller J; Bradshaw H; Straiker A
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6419-6426. PubMed ID: 27893106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
    Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that cannabinoid CB1 receptors regulate intraocular pressure via two opposing mechanisms.
    Miller S; Daily L; Ploss M; Greig I; Ross R; Rayana NP; Dai J; Sugali CK; Mao W; Straiker A
    Exp Eye Res; 2020 Nov; 200():108241. PubMed ID: 32941875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases.
    Chicca A; Arena C; Manera C
    Recent Pat CNS Drug Discov; 2016; 10(2):122-141. PubMed ID: 27630088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
    Kinsey SG; O'Neal ST; Long JZ; Cravatt BF; Lichtman AH
    Pharmacol Biochem Behav; 2011 Mar; 98(1):21-7. PubMed ID: 21145341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organophosphate agents induce plasma hypertriglyceridemia in mouse via single or dual inhibition of the endocannabinoid hydrolyzing enzyme(s).
    Suzuki H; Ito Y; Noro Y; Koketsu M; Kamijima M; Tomizawa M
    Toxicol Lett; 2014 Feb; 225(1):153-7. PubMed ID: 24361246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure.
    Miller S; Kulkarni S; Ciesielski A; Nikas SP; Mackie K; Makriyannis A; Straiker A
    Pharmaceuticals (Basel); 2018 May; 11(2):. PubMed ID: 29786643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184.
    Seillier A; Dominguez Aguilar D; Giuffrida A
    Pharmacol Biochem Behav; 2014 Sep; 124():153-9. PubMed ID: 24911644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
    Wilkerson JL; Ghosh S; Mustafa M; Abdullah RA; Niphakis MJ; Cabrera R; Maldonado RL; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Mar; 114():156-167. PubMed ID: 27890602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key Regions of Peripheral and Central Nervous System Implicated in Migraine.
    Della Pietra A; Giniatullin R; Savinainen JR
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
    Kinsey SG; Long JZ; O'Neal ST; Abdullah RA; Poklis JL; Boger DL; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2009 Sep; 330(3):902-10. PubMed ID: 19502530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid CB1 receptors regulate salivation.
    Andreis K; Billingsley J; Naimi Shirazi K; Wager-Miller J; Johnson C; Bradshaw H; Straiker A
    Sci Rep; 2022 Aug; 12(1):14182. PubMed ID: 35986066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological enhancement of endocannabinoid signaling reduces the cholinergic toxicity of diisopropylfluorophosphate.
    Nallapaneni A; Liu J; Karanth S; Pope C
    Neurotoxicology; 2008 Nov; 29(6):1037-43. PubMed ID: 18765251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.